Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001593:Benzyl Compounds / Q000494:pharmacology; D001923:Brain Chemistry / Q000187:drug effects*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004296:Dopa Decarboxylase; D004298:Dopamine / Q000032:analysis / Q000494:pharmacology; D006834:Hydrazines / Q000494:pharmacology; D051379:Mice; D009069:Movement Disorders; D009638:Norepinephrine / Q000032:analysis; D012110:Reserpine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D012640:Seizures; D012694:Serine / Q000494:pharmacology; D013016:Sound
D001593:Benzyl Compounds; D006834:Hydrazines; D012694:Serine; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D004296:Dopa Decarboxylase; D004298:Dopamine; D009638:Norepinephrine